Home/Filings/4/0001654954-19-013406
4//SEC Filing

RIOUX PATRICE 4

Accession 0001654954-19-013406

CIK 0001645469other

Filed

Nov 25, 7:00 PM ET

Accepted

Nov 26, 7:40 PM ET

Size

11.6 KB

Accession

0001654954-19-013406

Insider Transaction Report

Form 4
Period: 2019-11-26
Transactions
  • Exercise/Conversion

    Common Stock

    2019-11-26$6.00/sh+18,333$109,99818,333 total
  • Exercise/Conversion

    Common Stock

    2019-11-26$0.00/sh+100$018,433 total
  • Exercise/Conversion

    Stock options

    2019-11-2618,33313,671 total
    Exercise: $6.00Exp: 2027-12-31Common Stock (18,333 underlying)
  • Exercise/Conversion

    Stock options

    2019-11-261006,900 total
    Exercise: $0.00Exp: 2026-12-14Common Stock (100 underlying)
Holdings
  • Stock options

    Exercise: $6.00Exp: 2028-12-30Common Stock (20,000 underlying)
    20,000
Footnotes (3)
  • [F1]Original stock options to purchase up to 32,004 shares of common stock vested 12,000 shares upon grant date of January 1, 2018 and 1,667 shares on the first of each month thereafter.
  • [F2]Original stock options to purchase up to 7,000 shares of common stock vested: 1,190 shares on January 15, 2017; 1,120 shares on February 15, 2017; 1,190 shares on March 15, 2017; 1,120 shares on April 15, 2017; 1,190 shares on May 15, 2017; and 1,190 shares on June 15, 2017.
  • [F3]Stock options to purchase up to 20,000 shares of common stock vests 1,667 on January 31, 2019 and the last day of each subsequent month thereafter.

Issuer

Monopar Therapeutics

CIK 0001645469

Entity typeother

Related Parties

1
  • filerCIK 0001241033

Filing Metadata

Form type
4
Filed
Nov 25, 7:00 PM ET
Accepted
Nov 26, 7:40 PM ET
Size
11.6 KB